Drug
Dsp 7888 Dosing Emulsion
Dsp 7888 Dosing Emulsion: highest development phase Phase 3, developed by Sumitomo Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sumitomo Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| DSP-7888 Dosing Emulsion NCT03149003 | Phase 3 | Glioblastoma |
Latest
No recent events.
Follow Dsp 7888 Dosing Emulsion on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.